Liberta Co.,Ltd. Share Price

Equities

4935

JP3974810008

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 03/06/2024 BST 5-day change 1st Jan Change
1,213 JPY +2.45% Intraday chart for Liberta Co.,Ltd. -2.96% +76.05%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 9.23B 59.1M 4.63B Sales 2025 * 10.48B 67.11M 5.25B Capitalization 3.62B 23.22M 1.82B
Net income 2024 * 125M 801K 62.68M Net income 2025 * 180M 1.15M 90.26M EV / Sales 2024 * 0.39 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.35 x
P/E ratio 2024 *
29 x
P/E ratio 2025 *
20.1 x
Employees 118
Yield 2024 *
1.48%
Yield 2025 *
1.48%
Free-Float 34.96%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Liberta Co.,Ltd.'s Equity Buyback Plan announced on February 13, 2024. CI
Tranche Update on Liberta Co.,Ltd.'s Equity Buyback Plan announced on February 13, 2024. CI
Liberta Co.,Ltd.'s Equity Buyback announced on february 13, 2024, has closed with 10,400 shares, representing 0.35% for ¥10.96 million. CI
Liberta Co.,Ltd.'s Equity Buyback Plan Extended till August 31, 2024. CI
Tranche Update on Liberta Co.,Ltd.'s Equity Buyback Plan announced on February 13, 2024. CI
Liberta Co.,Ltd. announces an Equity Buyback for 15,000 shares, representing 0.5% for ¥11 million. CI
Liberta Co.,Ltd. agreed to acquire AFURA Co.,Ltd from Nobuyuki Yamaguchi for ¥180 million. CI
Liberta Co.,Ltd. authorizes a Buyback Plan. CI
Tranche Update on Liberta Co.,Ltd.'s Equity Buyback Plan announced on February 14, 2023. CI
Liberta Co.,Ltd.'s Equity Buyback announced on February 14, 2023, has closed with 18,900 shares, representing 0.64% for ¥13.45 million. CI
Liberta Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Liberta Co.,Ltd. agreed to acquire Fuji and Cherry Group Co., Ltd for ¥370 million. CI
Tranche Update on Liberta Co.,Ltd.'s Equity Buyback Plan announced on February 14, 2023. CI
Liberta Co.,Ltd. announces an Equity Buyback for 30,000 shares, representing 1.01% for ¥13.5 million. CI
Liberta Co.,Ltd. authorizes a Buyback Plan. CI
More news
1 day+2.45%
1 week-2.96%
Current month+2.45%
1 month+76.31%
3 months+61.73%
6 months+65.71%
Current year+76.05%
More quotes
1 week
1 040.00
Extreme 1040
1 272.00
1 month
673.00
Extreme 673
1 440.00
Current year
666.00
Extreme 666
1 440.00
1 year
666.00
Extreme 666
1 440.00
3 years
469.00
Extreme 469
1 440.00
5 years
469.00
Extreme 469
2 159.00
10 years
469.00
Extreme 469
2 159.00
More quotes
Managers TitleAgeSince
President 56 11/02/97
Chief Administrative Officer 53 30/11/00
Director/Board Member 46 31/07/07
Members of the board TitleAgeSince
Director/Board Member 67 31/08/18
President 56 11/02/97
Director/Board Member 55 31/10/99
More insiders
Date Price Change Volume
03/06/24 1,213 +2.45% 76 300
31/05/24 1,184 +0.59% 68,400
30/05/24 1,177 +6.90% 143,400
29/05/24 1,101 -8.71% 290,900
28/05/24 1,206 +2.38% 433,000

Delayed Quote Japan Exchange, June 03, 2024 at 07:00 am

More quotes
Liberta Co Ltd is a Japan-based company mainly engaged in the planning and sale of beauty products, toiletry products, functional clothing products and others, as well as the import watch agency business. The main products include cosmetic products such as peeling foot care products, deodorant creams, shavings and other cosmetics and quasi-drugs, toiletry products such as washing tub cleaners and household cleaners, functional clothing products, import watches, health and beauty miscellaneous goods, processed food products, as well as educational toys and other products. The brands include Baby Foot, QuickBeauty, DENTISTE’, KABIDASH, kabitornado, FREEZE TECH, HeatMaster, Luminox, Libenham, ThinOptics, ATHMEAL and others. The Company is engaged in the sale of products through department stores, mass retailers, drug stores, mail-order stores and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW